Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Looking for ways to make extra cash on weekends? Discover flexible gigs that can help you boost your income during your off days.
20,219 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
When a k-pop star left group, it isn’t just a headline. It sets off a wave of spending, policy shifts, and career rei...
PayPal has fallen sharply from its peak. This guide explains how to evaluate a potential dip buy, weighing risk, fund...
As millions of Baby Boomers retire, a fundamental shift is underway for markets and investment strategies. This story...
Palantir Technologies is at a crossroads as AI-driven data analytics demand tightens. This long-range look maps 2026-...
When a chief executive sells a large block of shares, investors understandably take note. This guide breaks down what...
A longtime investor reevaluates the urge to claim Social Security at 62, choosing to wait for bigger monthly checks a...
A timely tribute to Ted Turner and the daring moves that built a media empire. From billboard prince to cable mogul, ...
Microsoft stock fans are catching a sense of momentum after fresh signals point to upside. This guide unpacks what gr...
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...